Prot# ET-C-002-07: A Randomized, Multicenter, Phase III Trial of Trabectedin (Yondelis®) versus Doxorubicin-based Chemotherapy as First-Line Therapy in Patients with Translocation-Related Sarcomas (TRS)

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/10 → 1/21/14

Funding

  • Pharma Mar, S.A. Sociedad Unipersonal (ET-C-002-07)